Skip to main content
. 2018 Nov 27;73(Suppl 1):e543s. doi: 10.6061/clinics/2018/e543s

Table 3.

Univariate and multivariate analysis of disease-free survival and overall survival.

Disease-free Survival Univariate Multivariate
Variables* Hazard Ratio 95% CI p Hazard Ratio 95% CI p
Age 0-69 vs. ≥70 years 0.69 0.44-1.07 0.095
Female vs. Male 1.07 0.73-1.58 0.710
ASA I/II vs. III/IV 0.91 0.54-1.53 0.733
Charlson 0-1 vs. Charlson >1 0.87 0.44-1.72 0.693
Subtotal vs. Total gastrectomy 2.16 1.48-3.14 <0.001 1.83 1.26-2.67 0.002
D2 vs. D1 lymphadenectomy 1.10 0.64-1.89 0.737
Intestinal vs. Diffuse/mixed 1.91 1.30-2.79 0.001 1.44 0.98-2.17 0.062
pT1/pT2 vs. pT3/pT4 10.03 5.07-19.85 <0.001 4.6 2.20-9.68 <0.001
pN0 vs. pN1/2/3 8.48 4.65-15.46 <0.001 3.68 1.99-7.08 <0.001
Overall Survival Univariate Multivariate
Variables* Hazard Ratio 95% CI p Hazard Ratio 95% CI p
Age 0-69 vs ≥70 years 1.50 1.07-2.11 0.019 1.44 1.01-2.06 0.044
Female vs. Male 1.18 0.84-1.66 0.352
ASA I/II vs. III/IV 2.08 1.44-3.01 <0.001 1.68 1.10-2.56 0.016
Charlson 0-1 vs. Charlson >1 1.54 0.94-2.53 0.089
Subtotal vs. Total gastrectomy 1.58 1.13-2.21 0.008 1.61 1.14-2.25 0.006
D2 vs. D1 lymphadenectomy 2.19 1.48-3.24 <0.001 1.99 1.26-3.13 0.003
Intestinal vs. Diffuse/mixed 1.49 1.06-2.07 0.002 1.45 1.03-2.05 0.034
pT1/pT2 vs. pT3/pT4 2.92 1.96-4.36 <0.001 1.91 1.18-3.11 0.009
pN0 vs. pN1/2/3 3.03 2.06-4.47 <0.001 2.04 1.27-3.29 0.002

*The first variable represents the reference category.